why choose us

First received: April 01, 2023

Clinical Trial: Daily Adaptive Post-Prostatectomy With Stereotactic Ablative Radiotherapy in Patients With Prostate Cancer, DAPPER Study

Study Status: Completed

Recruit Status: RECRUITING

Condition: Malignant Prostate Neoplasm

Study Type: INTERVENTIONAL


Official Title: Daily Adaptive Post-Prostatectomy Radiation With Stereotactic Ablative Radiotherapy (DAPPER)

Brief Summary: This clinical trial evaluates the feasibility, safety, and tolerability of stereotactic ablative radiotherapy (SABR) using daily adaptive radiation techniques to the prostate fossa and/or pelvic lymph nodes in patients with prostate cancer who have undergone surgical removal of the prostate (radical prostatectomy).For patients with prostate cancer who develop a rising prostate specific antigen (PSA) after radical prostatectomy, salvage radiation therapy is the standard of care treatment.Radiation therapy uses…

Read more